There have been major advances in the armamentarium for hepatocellular carcinoma
(HCC) since the last official update of the Barcelona Clinic Liver Cancer prognosis and …

Liver cancer remains a global health challenge, with an estimated incidence of> 1 million
cases by 2025. Hepatocellular carcinoma (HCC) is the most common form of liver cancer …

Liver cancer is the fifth most common cancer and the second most frequent cause of cancer-
related death globally. Hepatocellular carcinoma represents about 90% of primary liver …

Advances in the surgical and systemic therapeutic landscape of hepatocellular carcinoma
have increased the complexity of patient management. A dynamic adaptation of the …

Hepatocellular carcinoma (HCC) is the most common primary tumor of the liver and its
mortality is third among all solid tumors, behind carcinomas of the lung and the colon …

Abstract Background The Child–Pugh (CP) score is used widely to assess liver function and
predict postoperative outcomes in patients with hepatocellular carcinoma (HCC). Recently …

Background Metabolic dysfunction-associated fatty liver disease (MAFLD) represents a new
inclusive definition of the whole spectrum of liver diseases associated to metabolic …

Treatment allocation is extremely complex in patients with hepatocellular carcinoma (HCC)
because this neoplasm arises, in most cases, in patients with cirrhosis and additional …

Abstract Background and Aims The study objective was to compare the effectiveness of
microwave ablation (MWA) and laparoscopic liver resection (LLR) on solitary 3–5‐cm HCC …

According to the American Association for the Study of Liver Diseases (AASLD) treatment
guidelines for hepatocellular carcinoma (HCC), the role of surgery has been expanded …